Trial Profile
Pharmacokinetic and Pharmacodynamic Study of CD 2027 3microg/g Oily Spray Applied Twice Daily for 3 Weeks Under Conditions of Maximized Use in Adults With Plaque-Type Psoriasis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2021
Price :
$35
*
At a glance
- Drugs Calcitriol (Primary)
- Indications Plaque psoriasis
- Focus Pharmacokinetics
- Sponsors Galderma
- 27 Oct 2009 New trial record.